Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trialHiddo J.L. Heerspink, Toby Coates, Stewart Bieler et al.|The Lancet|2023Cited by 214
Chronic Kidney Disease Itself Is a Causal Risk Factor for Stroke beyond Traditional Cardiovascular Risk Factors: A Nationwide Cohort Study in TaiwanYi‐Chun Chen, Shang‐Jyh Hwang|PLoS ONE|2012Cited by 54